Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
244.89
-1.39 (-0.56%)
Feb 25, 2026, 1:20 PM EST - Market open

Johnson & Johnson Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
19,70924,10521,85912,88914,487
Short-Term Investments
3934171,0689,39217,121
Cash & Cash Equivalents
20,10224,52222,92722,28131,608
Cash Growth
-18.02%6.96%2.90%-29.51%25.50%
Receivables
17,17814,84214,87314,03915,283
Inventory
14,19112,44411,18110,26810,387
Other Current Assets
4,1534,0854,5148,7063,701
Total Current Assets
55,62455,89353,49555,29460,979
Property, Plant & Equipment
23,16920,51819,89817,98218,962
Goodwill and Intangibles
99,17581,81870,73374,53681,638
Other Long-Term Assets
21,24221,87523,43239,56620,439
Total Long-Term Assets
143,586124,211114,063132,084121,039
Total Assets
199,210180,104167,558187,378182,018
Accounts Payable
11,99110,3119,6329,88911,055
Current Debt
8,4955,9833,45112,7563,766
Other Current Liabilities
33,64034,02733,19933,15730,405
Total Current Liabilities
54,12650,32146,28255,80245,226
Long-Term Debt
39,43830,65125,88126,88629,985
Other Long-Term Liabilities
24,10227,64226,62127,88632,784
Total Long-Term Liabilities
63,54058,29352,50254,77262,769
Total Liabilities
117,666108,61498,784110,574107,995
Total Debt
47,93336,63429,33239,64233,751
Debt Growth
30.84%24.89%-26.01%17.45%-4.30%
Retained Earnings
168,978155,791153,843128,345123,060
Comprehensive Income
-14,930-11,741-12,527-12,967-13,058
Shareholders' Equity
81,54471,49068,77476,80474,023
Net Cash (Debt)
-27,831-12,112-6,405-17,361-2,143
Net Cash Per Share
-11.46-4.99-2.50-6.52-0.80
Working Capital
1,4985,5727,213-50815,753
Book Value Per Share
33.8729.7027.1529.2628.12
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).